Journal article
023 Risk Stratification Using CHA2DS2-VASc and CHADS2 Scores in Patients With Chronic Atherosclerotic Cardiovascular Disease Receiving Aspirin With or Without Rivaroxaban: An Analysis of the COMPASS Trial
Authors
Sen J; Tonkin A; Varigos J; Fonguh S; Berkowitz S; Yusuf S; Verhamme P; Vanassche T; Anand S; Fox K
Journal
Heart Lung and Circulation, Vol. 29, ,
Publisher
Elsevier
Publication Date
2020
DOI
10.1016/j.hlc.2020.09.030
ISSN
1443-9506